RiverPark Advisors’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$216K Sell
2,166
-464
-18% -$42.5K 0.09% 89
2026
Q2
$253K Sell
2,630
-2,017
-43% -$184K 0.12% 86
2026
Q1
$172K Buy
4,647
+1,249
+37% +$40K 0.06% 93
2025
Q4
$68.6K Buy
3,398
+1,987
+141% +$48.1K 0.02% 132
2025
Q3
$42.5K Buy
+1,411
New +$30.6K 0.02% 124
2024
Q2
– Sell
-2,069
Closed -$25.7K – 132
2024
Q1
$25.7K Buy
2,069
+1,620
+361% +$27K 0.02% 125
2023
Q4
$11.9K Buy
449
+83
+23% +$2.42K 0.01% 105
2023
Q3
$16.7K Buy
+366
New +$17K 0.02% 97

Other funds holding AEHR

RiverPark Advisors's AEHR Position: Q3 2026 in Review

RiverPark Advisors reduced its Aehr Test Systems (AEHR) stake by 18% in Q3 2026, selling an estimated $42.5K and leaving 2,166 shares worth $216K. The position accounts for 0.09% of the portfolio, ranked #89.

RiverPark Advisors first reported a position in AEHR in Q3 2023 and has held it in 8 quarters since. The position peaked at $253K in Q2 2026. 298 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

  • RiverPark Advisors held 2,166 shares of Aehr Test Systems worth $216K as of Q3 2026.
  • RiverPark Advisors sold 464 Aehr Test Systems shares in Q3 2026, an estimated $42.5K.
  • Aehr Test Systems made up 0.09% of RiverPark Advisors's portfolio in Q3 2026, its #89 holding.
  • RiverPark Advisors first reported a position in Aehr Test Systems in Q3 2023 and has held it in 8 quarters since.
  • RiverPark Advisors's Aehr Test Systems position peaked at $253K in Q2 2026.
  • 298 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on RiverPark Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.